Trégoat Virginie, Montagne Paul, Béné Marie-Christine, Faure Gilbert
Groupe de Recherche en Immuno Pathologie, Immunology Laboratory, Faculty of Medicine, Vandoeuvre les Nancy, France.
J Clin Lab Anal. 2002;16(6):304-7. doi: 10.1002/jcla.10055.
The mannan binding lectin (MBL) activates the complement system by the lectin pathway after the recognition of some structural motifs (saccharides) present on the surface of microorganisms. MBL has been mostly identified and quantified in human serum by ELISA or microparticle immunonephelometry assays. This article reports the MBL levels as assessed by a microparticle immunonephelometric assay in 76 human milk samples. Immunonephelometry was performed using skim-milk samples diluted 20 times over a calibration range of 0.07-4.82 mg/L. MBL is indeed present in human milk and its concentration decreases significantly during development from colostrum (0.55+/-0.09 mg/L) to transitional (0.18+/-0.02 mg/L) and mature milk (0.17+/-0.02 mg/L). This innate molecule may be involved in the primary defenses of the mammary gland and the neonate, whose immune system is immature. The high levels observed during the first days of lactation support the hypothesis that this molecule plays a key role in limiting the colonization of the newborn gut by pathogens.
甘露聚糖结合凝集素(MBL)在识别微生物表面存在的某些结构基序(糖类)后,通过凝集素途径激活补体系统。MBL大多通过ELISA或微粒免疫比浊法在人血清中进行鉴定和定量。本文报告了通过微粒免疫比浊法对76份人乳样本中MBL水平的评估。使用稀释20倍的脱脂乳样本在0.07 - 4.82 mg/L的校准范围内进行免疫比浊法检测。MBL确实存在于人乳中,其浓度在从初乳(0.55±0.09 mg/L)到过渡乳(0.18±0.02 mg/L)和成熟乳(0.17±0.02 mg/L)的过程中显著降低。这种先天分子可能参与乳腺和新生儿的初级防御,新生儿的免疫系统尚未成熟。哺乳期最初几天观察到的高水平支持了这样一种假设,即该分子在限制病原体对新生儿肠道的定植方面起关键作用。